By Ethan Covey
Despite evidence that they can protect individuals from developing severe cases of COVID-19, monoclonal antibody (MA) therapies are being underuse in the United States, according to federal and state officials who participated in a teleconference on Jan. 14.
Health care professionals should increase use of the treatments to limit the strain on hospital systems, they said.
“We want to get the word out to Americans that although this has been a long year, there is a